RBC Capital Downgrades Biohaven to Sector Perform, Lowers Price Target to $19
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsDowngradesPrice Target
RBC Capital analyst Leonid Timashev downgrades Biohaven (NYSE:BHVN) from Outperform to Sector Perform and lowers the price target from $23 to $19.
RBC Capital analyst Leonid Timashev downgrades Biohaven (NYSE:BHVN) from Outperform to Sector Perform and lowers the price target from $23 to $19.